Target intelligence / Profile preview

Prefoldin subunit 6 (PFDN6)

Target
PFDN6
Molecular classification
Chaperone protein, Prefoldin complex subunit, Protein folding accessory
01

Overview

Prefoldin subunit 6 (PFDN6) is a protein chaperone that is one of six distinct components of the prefoldin complex (hexameric complex with subunits PFDN1–6), which is widely conserved in eukaryotes and archaea[2][3][4]. As part of the prefoldin complex, PFDN6 binds newly synthesized (nascent) proteins, especially cytoskeletal components actin and tubulin, and facilitates their proper folding and assembly by transferring them to the cytosolic chaperonin (CCT or TRiC) complex[1][3][4][5]. This ATP-independent binding prevents protein misfolding and aggregation, supporting cellular protein stability and the assembly of cellular structures such as the cytoskeleton[2][3][4]. Recent research suggests that PFDN6 expression is upregulated following cell activation (including immune cell activation), and overexpression has been linked to adaptive immune responses and certain cancers, suggesting a role as a disease biomarker and modulator of proteostasis in disease contexts[1]. Loss or dysregulation of prefoldin complex components can lead to defects in protein homeostasis and is implicated in protein misfolding diseases and tumor progression[3][4][5]. Currently, PFDN6 is not considered a direct therapeutic target (e.g., not a receptor, enzyme, transporter, or transcription factor), and there are no known drugs or mechanisms of action specifically targeting this protein.

Other names
HKE2H2-KE2PFD6KE-2Protein Ke2HLA class II region expressed gene KE2KE2 protein
02

Biological functions

Protein foldingCytoplasmic chaperone activityAssembly and stabilization of cytoskeletal proteins (actin, alpha- and beta-tubulin)Maintenance of protein homeostasis (proteostasis)
03

Disease associations

Cancer (possible roles in oncogenesis)Corneal depositNickel allergic contact dermatitisPotential role in immune function and adaptive immune response
04

Biomarkers

Overexpression may serve as a potential biomarker in certain cancers

Beyond the preview

Go deeper on Prefoldin subunit 6 (PFDN6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prefoldin subunit 6 (PFDN6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call